The HSV-1 tegument protein pUL46 associates with cellular membranes and viral capsids  by Murphy, Michael A. et al.
Virology 376 (2008) 279–289
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roTheHSV-1 tegument proteinpUL46associateswith cellularmembranes andviral capsids
Michael A. Murphy, Michelle A. Bucks, Kevin J. O'Regan, Richard J. Courtney ⁎
Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USAa r t i c l e i n f o⁎ Corresponding author. Fax: +1 717 531 6522.
E-mail address: rcourtney@psu.edu (R.J. Courtney).
0042-6822/$ – see front matter © 2008 Elsevier Inc. Al
doi:10.1016/j.virol.2008.03.018a b s t r a c tArticle history:
Received 25 October 2007
Returned to author for revision
25 February 2008
Accepted 18 March 2008
Available online 2 May 2008The molecular mechanisms responsible for the addition of tegument proteins into nascent herpesvirus
particles are poorly understood. To better understand the tegumentation process of herpes simplex virus
type 1 (HSV-1) virions, we initiated studies that showed the tegument protein pUL46 (VP11/12) has a similar
cellular localization to the membrane-associated tegument protein VP22. Using membrane ﬂotation analysis
we found that pUL46 associates with membranes in both the presence and absence of other HSV-1 proteins.
However, when puriﬁed virions were stripped of their envelope, the majority of pUL46 was found to associate
with the capsid fraction. This strong afﬁnity of pUL46 for capsids was conﬁrmed by an in vitro capsid pull-
down assay in which puriﬁed pUL46-GST was able to interact speciﬁcally with capsids puriﬁed from the
nuclear fraction of HSV-1 infected cells. These results suggest that pUL46 displays a dynamic interaction
between cellular membranes and capsids.











Herpes simplex virus (HSV) assembly follows a set of sequential
events that culminate in the production of a virion composed of distinct
morphological structures. These structural components include the
nucleocapsid, the glycoprotein containing lipid envelope, and the
tegument, which is a proteinacious layer located between the
nucleocapsid and envelope (Roizman and Sears, 2001). Similar to
other herpesviruses, HSV assembles in multiple cellular compartments
(Enquist et al., 1998; Mettenleiter, 2000, 2002, 2004). Capsid formation
and the packaging of viral DNA occur within the nucleus of the infected
cell. Nucleocapsids exit the nucleus into the cytoplasm by an envelop-
ment/de-envelopment process through the inner and outer leaﬂets of
the nuclear membrane. Cytoplasmic capsids obtain their envelope by
budding into vesicles derived from the trans-Golgi network (TGN).
These vesicles are eventually shuttled to the cell periphery where
membrane fusion results in the release of virions from the cell.
The incorporation of tegument proteins into nascent viral particles
is thought to occur at multiple stages throughout the virus assembly
process. Recent studies suggest that the tegumentation of capsids
begins within the nucleus. We have recently reported the binding of
tegument proteins VP1/2 and pUL37 to capsids within the nucleus of
virus-infected cells (Bucks et al., 2007). In addition, the vhs (pUL41)l rights reserved.tegument protein is also associated with capsids isolated from nuclei
of infected cells (Read and Patterson, 2007). Additional tegument
proteins may be added during primary envelopment of capsids at the
inner nuclearmembrane. For example, VP16 is associated with capsids
found between the inner and outer nuclear membrane (Naldinho-
Souto et al., 2006). This result coupled with the ﬁnding that VP16 is
undetectable on capsids isolated within the nucleus, suggests that a
subpopulation of VP16 becomes associated with capsids during
primary envelopment (Read and Patterson, 2007; Yao and Courtney,
1992). Several tegument proteins are added to capsids in the
cytoplasm when they bud into vesicles derived from the TGN
(Gershon et al., 1994; Granzow et al., 1997, 2001; Harley et al., 2001;
Mettenleiter, 2002, 2004; Sanchez et al., 2000; Skepper et al., 2001;
van Genderen et al., 1994; Whealy et al., 1991; Whiteley et al., 1999;
Zhu et al., 1995). The numerous interactions that occur at these
vesicles between viral glycoproteins and tegument proteins suggest
an assembly strategy ensuring incorporation of the full complement of
tegument (Chi et al., 2005; Farnsworth et al., 2007; Fuchs et al., 2002;
Gross et al., 2003; Kamen et al., 2005; O'Regan et al., 2006; Zhu and
Courtney, 1994). However, tegument proteins are not solely reliant
upon glycoproteins for their recruitment to membranes. For example,
the tegument proteins pUL11, VP22 and vhs associate with cellular
membranes in the absence of other viral proteins (Brignati et al., 2003;
Loomis et al., 2001; Mukhopadhyay et al., 2006). It is likely that these
tegument proteins, as well as others, are incorporated into virions at
these membranous sites.
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12) is an abundant tegument protein (approximately 1200molecules per
virion) associated with HSV particles (Heine et al., 1974; Zhang and
McKnight, 1993). This tegument protein is observed as two different
migrating species (between 80 and 90 kDa) by SDS-PAGE and this
variation may be due to different levels of phosphorylation (Kato et al.,
2000; Lemaster and Roizman,1980; Zhang andMcKnight,1993;Willard,
2002). One reported role for pUL46 in viral replication, as well as pUL47
(VP13/14), is to enhance the trans-activation of immediate earlygenes, an
eventprimarilyorchestratedbyVP16 (Katoet al., 2000; Zhanget al.,1991;
Zhang andMcKnight,1993). Even though pUL46 and VP16 are capable of
interacting, the mechanism for modulation of VP16 activity is currently
unknown (Vittone et al., 2005). During infection, pUL46 is localized
within the cytoplasm asmultiple puncta and this phenotype is similar to
the localization of the membrane-associated protein VP22, suggesting
pUL46 may also associate with membranes (Brignati et al., 2003; Kato
et al., 2000; Murata et al., 2000; Nozawa et al., 2004; Willard, 2002).
In the current study, we expressed pUL46 by transient transfection
as well as in the context of a virus infection to determine the cellular
location of the protein. Our studies indicate pUL46 is associated with
cellular membranes and that this association does not require the
presence of other viral proteins. Surprisingly, membrane association
within the cell did not translate to association of this protein with the
viral envelope, as pUL46 exhibited a strong afﬁnity for the capsid of
puriﬁed virus particles.
Results
pUL46 and VP22 display a punctate cytoplasmic localization in
HSV-infected and transfected cells
During HSV-1 infection, pUL46 accumulates as discrete puncta
throughout the cytoplasm (Willard, 2002). Previous studies from ourFig. 1. Cellular localization of pUL46 and VP22. A) Vero cells were infected with the pUL46-G
and permeabilized. VP22 was detected with anti-VP22 serum followed by addition of a secon
with plasmids encoding pUL46-HA and VP22-GFP. At 24 h post-transfection the cells were
followed by the addition of a secondary antibody conjugated to Alexa 555. In order to visualaboratory and others have shown that another abundant tegument
protein, VP22, is also expressed as distinct puncta within the
cytoplasm (Brignati et al., 2003; Elliott et al., 1999). To compare the
localization of pUL46 and VP22 during infection, we used a
recombinant virus (GHSV-UL46) that expresses pUL46-GFP to infect
Vero cells and an antibody against VP22 to compare the respective
cellular localization of the two proteins. It has been previously
reported that the growth of GHSV-UL46 is unaffected by the pUL46-
GFP fusion (Willard, 2002). Confocal microscopy of the resulting
ﬂuorescence showed that pUL46-GFP and VP22 exhibit punctate
localization within the cytoplasm (Fig. 1A). Additionally, the observed
ﬂuorescence indicated that the two proteins colocalized in numerous
regions; thesemay represent vesicles involved in ﬁnal envelopment of
the virus particle. In order to study the targeting properties of pUL46
in the absence of other viral proteins, the UL46 coding sequence was
cloned into a plasmid that upon expression would produce an HA-
tagged pUL46 protein (pUL46-HA). pUL46-HA and VP22-GFP encoding
constructs were cotransfected into A7 cells and ﬁxed prior to analysis
by confocal microscopy. We elected to use A7 cells for the transfection
confocal experiments because VP22 expressed via transfection in Vero
cells has a ﬁlamentous appearance due to the protein's ability to bind
microtubules (Elliot and O'Hare, 1997, 1998). We have found that VP22
expressed by transfection or infection in A7 cells does not exhibit this
localization, but appears as punctate structures in the cytoplasm.
Therefore, localization of VP22 expressed during transfection of A7
cells more closely resembles the localization of VP22 during infection
of other cell types. pUL46-HA and VP22-GFP expression within trans-
fected cells resulted in punctate ﬂuorescence that was larger than that
observed when both proteins were expressed in virus-infected cells
(Fig. 1B). Additionally, pUL46 and VP22 appeared to colocalize at
multiple sites within the cytoplasm, particularly in the perinuclear
region. To assure the observed ﬂuorescence was speciﬁc, infected cells
were incubated with pre-immune rabbit serum and untransfectedFP expressing GHSV-UL46 virus at a MOI of 10. At 9 h post-infection the cells were ﬁxed
dary antibody conjugated to Alexa 555. Scale bar=28 μm. B) A7 cells were cotransfected
ﬁxed and permeabilized. pUL46 was detected with an antibody against the HA epitope
lize the nuclei (blue ﬂuorescence) the cells were mounted in DAPI. Scale bar=30 μm.
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cence processing. Confocal microscopy analysis of these cells showed
no ﬂuorescence above background levels (data not shown).
pUL46 associates with cellular membranes
By confocal microscopy, the cellular localization of pUL46 in the
absence of HSV-1 infection was similar to that observed with VP22,
suggesting that pUL46 may also associate with cellular membranes. To
determine if pUL46 is indeed associated with membranes, lysates from
Vero cells transfected with the pUL46 encoding plasmid were analyzed
by a membrane ﬂotation assay. The lysates were mixed with sucrose to
yield a 72% sucrosemixture that was sequentially overlaidwith 65% and
10% sucrose to form a discontinuous density gradient. Due to the
buoyant density of membranes, ultracentrifugation results in the
ﬂotation of membrane-associated proteins to the interface between
the 65% and 10% sucrose layers. Western blot analysis of the membrane
ﬂotation gradients show that a substantial amount of pUL46 was
detected in fractions 10 and 11, where membrane-associated proteins
are normally found (Fig. 2). In addition, somepUL46was alsodetected in
the bottom 3 fractions corresponding to non-membrane associating
proteins. Quantitation of the pUL46 present in the membrane fraction
was determined by densitometry. The average of 3 independent
experiments showed 58% of pUL46 within the gradient was located in
the membrane-containing fractions. In order to determine the nature
and strength of the pUL46 associationwith cellular membranes, lysates
were treated prior to the ﬂotation assay with reagents known to extract
proteins from membranes. Association of pUL46 with membranes was
not altered when lysates were treated with either 1 M NaCl or 4 M urea
(54% and 63% of protein within the membrane-containing fractions
respectively). In addition, incubation of lysates with 0.1 M sodium
carbonate did not grossly alter themembrane association proﬁle (48% of
protein within the membrane-containing fractions), suggesting mem-
braneﬂotation is not the result of pUL46 residingwithin cellular vesicles
(Fujiki et al., 1982). To illustrate the speciﬁcity of the membraneFig. 2. Membrane association of pUL46 in the absence of additional HSV-1 proteins.
Vero cells were transfected with plasmids encoding pUL46HA or VP16. At 24 h post-
transfection, cells were scraped into PBS, washed and resuspended in hypotonic buffer
and lysed by passing through a 25 gauge needle. Post-nuclear supernatants (PNS) were
obtained by centrifugation of lysates at 500 ×g for 10 min. The resulting PNS were either
untreated or incubated with 1 M NaCl, 0.1 M Na2CO3, 4 M urea, or 1% Triton X-100 for
30 min at 4 °C. Following treatment, the lysates were loaded at the bottom of a
discontinuous 72–65–10% w/v sucrose gradient and centrifuged at 150,000 ×g for 18 h.
Gradients were fractionated from the bottom, TCA precipitated and analyzed by
Western blotting with antibodies against either the HA epitope or VP16. Fractions 1–3
contain non-membrane-associated proteins while fractions 10 and 11 correspond to the
65–10% interface containing cellular membranes.association assay, pUL46 containing lysates were treated with 1% Triton
X-100 prior to gradient analysis to solubilize membranes. Additionally,
lysates from cells transfected with a plasmid encoding VP16, a non-
membrane associating HSV-1 protein, were analyzed by the membrane
ﬂotation assay. The resulting VP16 containing lysates were processed
identically as the pUL46 containing lysates, followed by Western
blotting of the gradient fractions with anti-VP16 serum. pUL46 in the
absence of membranes (solubilized by Triton X-100) and VP16 in the
presence of membranes remained in the bottom of the gradient within
the non-membrane containing fractions. The above results suggest that
detectable amounts of pUL46 expressed within transfected cells are
strongly associated with cellular membranes.
Modiﬁed forms of the pUL46 protein associate with membranes
In order to determine if viral infection alters membrane association
of pUL46, the pUL46-HA encoding plasmid was transfected into Vero
cells followed by mock infection or infection with HSV-1 K23Z, a VP23
triplexnullmutant (Desai et al.,1993; PersonandDesai,1998). As a result
of this mutation, capsid assembly does not occur within infected cells.
Use of this virus was required becausewewished to analyzemembrane
association of pUL46 that is independent of its incorporation into
cytoplasmic virions. Western blot analysis of the gradient fractions
showed that pUL46 in K23Z infected cells is present in both membrane
andnon-membrane fractions, fractions 10 and1–3 respectively (Fig. 3A).
Results from themembrane ﬂotation analysis of transfected/infected
lysates showed the appearance of multiple proteins recognized by the
anti-HA antibody. In order to verify that these proteins are indeedUL46-
HA modiﬁed forms and not viral proteins or infection-induced cellular
proteins we performed Western blotting using anti-HA antibody on
lysates from 1) mock-transfected/mock-infected cells, 2) infected only
cells, 3) transfected only cells and 4) transfected/infected cells (Fig. 3B).
TheWestern blots show thatmultiple forms of pUL46 are only observed
in the transfected/infected cell lysates. In an effort to determine at what
time post-infection themodiﬁed forms of pUL46 are detectable, pUL46-
HAtransfected cellswere assayed at various times after infection. At 24h
post-transfection, Vero cells were either mock-infected or infected and
then harvested at 2 h intervals between 2 and 10 h post-infection. As
early as 6 h post-infection, multiple species of pUL46 were observed
(Fig. 3C). An additional 10 h post-infection sample was treated with
cyclohexamide during the entire course of infection to inhibit protein
synthesis. In the absence of protein synthesis, the multiple pUL46
species were not observed, suggesting that themodiﬁcation of pUL46 is
not due to a protein present in the incoming virion. The time course
analysis also revealed the presence of additional pUL46 species of lower
molecular weight. These lower molecular weight species were not
detected in the ﬂotation assays, which may be due to the use of post-
nuclear supernatants versus whole cell lysates used for the time course
experiments.
Because pUL46 is phosphorylated within the virion, it seemed
likely that these bands may represent hyper-phosphorylated species
of pUL46 resulting from phosphorylation by cellular or virally-
encoded kinases (Kato et al., 2000; Lemaster and Roizman, 1980;
Zhang and McKnight, 1993). To determine if phosphorylation is the
modiﬁcation responsible for the slower migrating proteins, pUL46
was immunoprecipitated from transfected/infected cell lysates and
incubated with either buffer only or calf intestinal alkaline phospha-
tase (CIAP). Treatment of immunoprecipitated pUL46 with CIAP
resulted in the loss of detectable modiﬁed forms of the protein
found in the untreated sample, indicating the slower migrating forms
are hyper-phosphorylated (Fig. 3D).
To elucidate which of the modiﬁed protein species of pUL46 is
associated with extracellular virions, we assayed extracellular virions
from transfected/infected cells. Vero cells were transfected with
the pUL46-HA encoding plasmid followed by infection 20 h post-
transfectionwith wild type HSV-1. At 20 h post-infection, extracellular
Fig. 3.Membrane association andmodiﬁcation of pUL46 during HSV-1 infection. A) Vero cells were transfected with the pUL46HA expressing plasmid. At 20 h post-transfection, cells
were infectedwith the K23Z virus (defect in synthesis of the triplex protein VP23) at aMOI of 10 for 12 h. At 12 h post-infection, the cells were harvested and processed for membrane
ﬂotation analysis by density gradient centrifugation as described in Fig. 2, followed by Western blotting with anti-HA antibody. B) Vero cells were either mock-transfected (lanes 1
and 2) or transfected (lanes 3 and 4) with the pUL46HA expressing plasmid. At 20 h post-transfection, the cells were either mock-infected (lanes 1 and 3) or infected (lanes 2 and 4)
with the KOS virus at a MOI of 10. At 12 h post-infection the cells were solubilized in SDS-PAGE buffer for subsequent Western blotting with anti-HA antibody. The membranes were
subsequently reprobed with anti-VP16 and anti-Actin antibodies. C) Vero cells were transfected with the pUL46HA expressing plasmid. At 20 h post-transfection, the cells were
infected with the K23Z virus (except those indicated as mock) at a MOI of 10. Cells were harvested and solubilized in SDS-PAGE sample buffer at the indicated times post-infection.
Additional pUL46HA transfected cells were mock (Mock+CHX) and K23Z infected (Infected+CHX) followed by cycloheximide treatment (10 μg/ml) immediately following viral
adsorption. Cyclohexamide treatment and infectionwere allowed to proceed for 10 h, at which time cells were solubilized in SDS-PAGE sample buffer. Samples were then analyzed by
Western blotting with anti-HA antibody. D) Vero cells were transfected with the pUL46HA expressing plasmid. At 20 h post-transfection, the cells were infected with KOS at a MOI of
10. At 20 h post-infection (40 h post-transfection), the cells were solubilized in lysis buffer, followed by immunoprecipitation of the pUL46-HA fusion proteins. The
immunoprecipitated proteins were either untreated or treated with 50 U of phosphatase (CIAP) for 30 min followed by Western blotting with anti-HA antibody. E) Vero cells were
transfected with the pUL46-HA expressing plasmid. At 20 h post-transfection, the cells were infected with KOS at a MOI of 10. Medium was removed from the cells at 20 h post-
infection (40 h post-transfection). Virions were pelleted from themedium through a 30% sucrose cushion. The puriﬁed virions and infected cells were solubilized in SDS-PAGE sample
buffer and analyzed byWestern blotting with anti-HA antibody. Based on the position of the molecular weight markers, the asterisks indicate the approximate locationwhere pUL46
expressed in transfected cells would migrate in the gel.
282 M.A. Murphy et al. / Virology 376 (2008) 279–289virions were pelleted through a sucrose cushion and analyzed for the
presence of pUL46-HA by Western blotting with anti-HA. Western
blots of the transfected–infected lysates showed a protein proﬁle
similar to that of the membrane ﬂotation assay (Fig. 3E). Extracellularvirions contained two forms, one minor form that is smaller than full-
length pUL46 whichmay represent a pUL46 breakdown product and a
major form that is of equal size to pUL46 expressed in uninfected/
transfected cell lysates (Fig. 3E).
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The above results suggest that pUL46 is associated with cellular
membranes in both the absence and presence of other viral proteins. In
an effort to determine the domain(s) of pUL46 responsible for its
association with cellular membranes, we constructed amino- and
carboxy-terminal deletions of the UL46 gene and inserted these into
the HA expression vector (Fig. 4A). Each fusion proteinwas expressed in
Vero cells and analyzed for its ability to associatewithmembranes based
on the density gradient membrane assay (described in Fig. 2). Western
blots of the gradient fractions showed that removal of the N-terminal
136 or 277 amino acids does not inhibit membrane association of the
respective truncated pUL46 proteins (Fig. 4B). However, removal of the
N-terminal 446 amino acids substantially reduced membrane associa-
tion of the protein. Analysis of the carboxy-terminal truncationmutants
showed that removal of amino acids from the carboxy terminus,
including the largest deletion that left residues 1–277 intact, did not
decrease membrane association. These results suggest that multiple
domains within pUL46 may facilitate membrane-binding, one present
within amino acids 1–277 and a second domain within amino acids
278–446.
Location of pUL46 within the HSV-1 virion
Association of pUL46 with cellular membranes could suggest that
the protein is localized within the outer tegument region of virions.
Other tegument proteins (i.e. pUL11 and VP22) found to interact with
either membranes or HSV-1 glycoproteins are found in close
association with the viral envelope of the mature virion (Wolfstein
et al., 2006). To facilitate these and future studies with pUL46, we
generated an antisera to pUL46 raised against puriﬁed pUL46-GST
expressed in E. coli. Speciﬁcity of the antiserum as analyzed by
Western blotting is shown in Fig. 5A and indicates the detection of a
protein of approximately 88 kDa associated with HSV virus particles
and a protein of approximately 115 kDa in pUL46-GFP encoding
virions. In addition, this anti-pUL46 antiserum detected the modiﬁed
forms of pUL46 expressed during wild type virus infection (data not
shown). To determine the location of pUL46 within the virion, virus
particles puriﬁed from the media of virus-infected cells were mock
treated or treated with 1% NP-40 to remove the viral envelope. The
virus preparations were then subjected to rate-zonal centrifugation inFig. 4. Residues responsible for membrane association. A) Schematic representation of pUL4
encoding an HA epitope tag. Numeric ranges indicate residues present in each construct. B) E
24 h post-transfection, the cells were scraped into PBS, washed, and resuspended in hypoton
were analyzed for the ability to associate with membranes as described in Fig. 2. Fractions 1–3
associating proteins.a 20–50% sucrose gradient. Fractions from the gradient were TCA
precipitated and analyzed by Western blotting to detect the major
capsid protein, VP5 and various tegument proteins including pUL46.
Western blots of the gradient fractions containing virions not treated
with NP-40 showed that most of the VP5 and pUL46 were detected in
the middle fractions of the gradient, the position one expects to detect
enveloped virus particles (Fig. 5B). Western blots of gradient fractions
of virus treated with NP-40 showed that the majority of the pUL46
protein was found in the same fractions containing the capsid protein
VP5 (Fig. 5C) with relatively small amounts of pUL46 detected at the
top of the gradient. In an effort to compare the location of pUL46 with
other tegument proteins following solubilization of the viral envelope
with NP-40, the blots were reprobed with antisera against the
membrane-bound pUL11 as well as VP16, VP22, and pUL37 (Fig. 5C).
In order to quantitate the relative amounts of each protein associated
with virus particles, the total signal in the gradients of three
independent experiments was analyzed by densitometry and dis-
played in Fig. 5D. Proteins detected in the bottom ﬁve fractions (1–5)
were considered to be associated with capsids, while those in the top
ﬁve fractions (6–10) were considered to be associated with the
envelope as indicated by their solubilization following NP-40 treat-
ment. Following NP-40 treatment, approximately 80 percent of pUL46
cosedimented with capsids as detected in the gradient fractions.
Similarly, the majority of the inner tegument protein pUL37 was also
found in the capsid fractions. In contrast, the three other tegument
proteins (pUL11, VP16, and VP22) were mostly detected in the upper
fractions of the gradient indicating their solubilization and release
from the envelope/tegument following NP-40 treatment. In addition,
Western blotting of the gradient fractions using antibody against gE
showed NP-40 treatment completely removed the viral envelope
(data not shown). It appears that the majority of the virion-associated
pUL46 remains associated with the viral capsid following treatment
with the detergent NP-40 suggesting that this protein is associated
with the inner layer of the tegument.
pUL46 interacts with HSV-1 capsids
Results from the above experiments suggest pUL46 is in close
association with the viral capsid. To further address this observation
we performed an in vitromixing experiment using HSV-1 capsids and
puriﬁed UL46-GST fusion protein. Capsids were puriﬁed from the6 mutants. Amino- and carboxy-terminal deletion constructs were cloned into a vector
ach deletion construct represented by the schematic was transfected into Vero cells. At
ic lysis buffer. Following mechanical lysis and centrifugation, the resulting supernatants
contain the non-membrane associating proteins and fractions 9–10 contain membrane
Fig. 5. Location of pUL46 within the HSV-1 virion. (A) Antibodies were raised in rabbits against pUL46-GST for use in Western blotting. To determine speciﬁcity of the antisera,
extracellular virus (KOS and GHSV-UL46) was pelleted, solubilized, and separated by SDS-PAGE. The proteins were transferred to nitrocellulose and probed with anti-pUL46GST
serum. B and C) Extracellular KOS virus was pelleted through 30% sucrose and resuspended in 1 M NaCl PBS. Virions were incubated in the absence (B) or presence (C) of 1% NP40 for
30 min at 4 °C. Following incubation, the samples were centrifuged on a 20–50% sucrose gradient. Gradients were then fractionated, TCA precipitated, and analyzed by Western
blotting with antibodies against various tegument proteins. D)Western blots of each tegument proteinwere quantitated by densitometry. Fractions 1–5were considered to represent
capsid-associated protein, while fractions 6–10were considered to represent envelope associated protein. Percent of total proteinwas calculated by dividing the sums of fractions 1–5
or 6–10 by the total amount of signal in fractions 1–10. The results represent data from 3 independent experiments.
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We have shown that isolation of nuclear capsids, as described in the
Materials and methods, are free of detectable cytoplasmic contamina-
tion (Bucks et al., 2007). Capsids were then mixed with GST, pUL11-
GST, or pUL46-GST immobilized on glutathione beads. Following
incubation, the washed beads were then mixed with SDS-sample
buffer and analyzed by SDS-PAGE and Western blotting with anti-VP5
(Fig. 6A) and anti-GST (Fig. 6B). Detection of VP5 in the pUL46-GST
lane suggests an interaction of capsids with pUL46 (Fig. 6A). In
contrast, the absence of detectable VP5 when GST or pUL11-GST was
mixed with capsids suggests a lack of binding to capsids.
In order to verify that pUL46 is interacting with intact capsids and
not monomeric VP5, the above fusion protein samples were also
analyzed for the presence of HSV-1 genomic DNA. Primers recognizingthe HSV-1 UL47 gene were used for PCR ampliﬁcation of DNA found
within the GST and UL46-GST samples. Analysis of the resulting PCR
products showed no detectable UL47 DNA within the GST sample
while the pUL46-GST sample contained ampliﬁed UL47 DNA even at a
1:100 dilution (Fig. 6C). These results provide additional conﬁrmation
of the speciﬁc interaction of pUL46 with capsids.
Discussion
With approximately 20 different tegument proteins in each HSV-1
virion, understanding how the tegument is added to the nascent
capsid has been challenging. One plausiblemechanism is suggested by
the multiple tegument protein–glycoprotein interactions that have
been identiﬁed (Chi et al., 2005; Fuchs et al., 2002; Gross et al., 2003;
Fig. 6. pUL46 interacts with HSV-1 capsids. A) KOS strain capsids were puriﬁed from nuclei of infected Vero cells harvested at 18 h post-infection. Capsids were incubated with either
GST, pUL46-GST, or pUL-11GST beads for 30min followed bymultiplewashes. After washing, SDS-PAGE sample buffer was added to 50% of the beads for subsequentWestern blotting.
In order to detect the presence of HSV-1 capsids, membranes were probed with antibody against VP5. B) The blots were subsequently stripped and probed with antibodies against
GST to detect GST and the respective fusion proteins. C) The remaining beads from GST-capsid pulldowns were analyzed for the presence of HSV-1 genomic DNA using the Qiagen
DNeasy Kit. The resulting DNA was serially diluted and used as a template for PCR ampliﬁcation of the UL47 gene.
285M.A. Murphy et al. / Virology 376 (2008) 279–289Ng et al., 1998; O'Regan et al., 2006; Zhu and Courtney, 1994). These
interactions may enable the sequential addition of tegument proteins
during both primary envelopment and secondary envelopment, due
to the presence of glycoproteins within the lipid bilayer of the inner
nuclear membrane and those found in TGN-derived vesicles. For
example, VP16 has been shown to interact with the cytoplasmic
domain of glycoproteins gB, gD, and gH, thereby facilitating its incor-
poration into the virus particle (Gross et al., 2003; Kamen et al., 2005;
Zhu and Courtney, 1994). This tegument protein may be added at
multiple sites, beginning in the nucleus as evidenced by recent
transmission immunogold electron microscopy studies (Naldinho-
Souto et al., 2006). Additional VP16 may be added to the tegument
during ﬁnal envelopment, as suggested by accumulation of the VP16
protein at the TGN when expressed in the presence of VP22 (Elliott
et al., 1995). The role of VP16 in the tegumentation process may be
pivotal based on the observed block in ﬁnal envelopment in cells
infected with a VP16 null virus (Mossman et al., 2000; von Einem
et al., 2006; Weinheimer et al., 1992).
The designation of “inner” and “outer” tegument proteins suggests
there is amore complex network of tegument assembly. If all tegument
proteins relied solely upon their association with the membrane
associating glycoproteins for incorporation into the viral particle, one
might expect that all of the tegument proteins would dissociate from
the capsid upon removal of the envelope either by detergent treatment
or following deposition of the capsid into the cytoplasm following viral
entry. However, it has been shown that pUL13, pUL36, and pUL37 are
associated with capsids following stripping of the envelope with
detergent (Morrison et al., 1998; Schmitz et al., 1995). Additionally,pUL37, pUL36, and pUS3 remain associated with the incoming capsids
as they traverse the cytoplasm towards the nucleus (Granzow et al.,
2005).
The goal of the current study was to determine if the tegument
protein pUL46 follows a similar incorporation strategy to other well-
characterized tegument constituents. Multiple HSV-1 proteins (vhs,
pUL51, pUL11, and VP22) have been reported to associate with cellular
membranes in the absence of other viral proteins (Brignati et al., 2003;
Loomis et al., 2001; Mukhopadhyay et al., 2006; Nozawa et al., 2004).
Ourmembraneﬂotation assays demonstrated that pUL46 is also capable
of associating with cellular membranes in both the absence and
presence of other viral proteins. The number of pUL46 encoded protein
products differed when expressed in the absence or presence of HSV-1
infection, a modiﬁcation likely due to phosphorylation. The detection of
modiﬁed pUL46 at 6 h post-infection and a lack of detectable modiﬁ-
cation during cycloheximide treatment, suggests that the responsible
kinase must be synthesized de-novo. The two HSV-1 encoded kinases
that may be responsible for the putative phosphorylation of pUL46 are
pUL13 and pUS3 (Cunningham et al., 1992; Zhang et al., 1990). It is also
possible that a cellular kinase is activated upon HSV infection, resulting
in hyper-phosphorylation of pUL46. Results from the membrane
ﬂotation assay show that phosphorylation of pUL46 does not affect its
association with membranes. However, analysis of virion-associated
pUL46 shows that only the hypo-phosphorylated form is incorporated
into extracellular virus. How the exclusion of hyper-phosphorylated
pUL46 from HSV-1 virions occurs is unclear. Potential possibilities
include but are not limited to, a protein–protein interaction that is
abrogated by hyper-phosphorylation of pUL46, a phosphatase activity
Fig. 7.Model of HSV-1 secondary envelopment resulting in capsid association of pUL46
in the mature virion. HSV-1 capsid (previously bound tegument proteins omitted for
clarity) transits the cytoplasm toward the site of secondary envelopment. pUL46 is
associated with cellular membranes prior to wrapping of the glycoprotein/tegument
protein coated vesicle around the viral capsid. During secondary envelopment, capsid
and membrane interfaces come into close proximity allowing protein–protein
interactions to occur between membrane-bound proteins and capsid-bound proteins.
Upon completion of secondary envelopment the capsid and envelope interfaces
separate, resulting in pUL46 preferentially associating with the capsid.
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pUL46. The exclusion of hyper-phosphorylated pUL46 fromvirions may
be a regulatory mechanism contributing to virion disassembly upon
entry into the cell. This potential requirement formaintaining tegument
proteins in a hypo-phosphorylated state is suggested by the ﬁndings
that phosphorylation plays a role in tegument protein dissociation from
the viral capsid (Morrison et al., 1998).
Mapping of the domains responsible for membrane association of
pUL46 did not yield clearly identiﬁable regions. One reason for this
may be that some deletions resulted in disruptive protein folding that
may expose stretches of amino acids that could interact with
membranes that are not exposed in the context of the full-length
pUL46. This ambiguity could also be due to a requirement for multiple
domains in order to associate with membranes. These domains may
reside within the region comprising the amino-terminal 446 amino
acids, suggested by the loss of membrane association upon deletion of
this region. Furthermore, confocal microscopy showed that removal of
these 446 amino acids results in nuclear localization of the truncation
mutant, while the other truncation mutants were all localized in the
cytoplasm (data not shown). Perhaps the loss of membrane-binding
facilitates this nuclear accumulation. To determine the relative
evolutionary importance of this membrane-binding region, we
compared the amino acid sequences of pUL46 homologs across 6
alpha herpesviruses. The resulting sequence alignment showed 28%
conservation for amino acids 1–446, while the residues 447–722
showed only 2% conservation.
Membrane association of pUL46 within the cell suggested that the
proteinwould interactwith components of the viral envelope. However,
removal of the viral envelope from extracellular virions failed to
dissociate the majority of pUL46 from the viral capsids. In contrast,
most of the VP22, VP16, and pUL11 were dissociated from the viral
capsids upon envelope removal. The pUL46 resistance to detergent-
mediated capsid dissociation suggests an interaction between pUL46
and the capsid. Whether or not pUL46 interacts directly with the capsid
or another viral protein that is associated with the capsid is currently
under investigation. The capsids for the in vitro capsid pull-down assay
were puriﬁed from nuclei. Studies show that the majority of tegument
proteins are added to the capsid in the cytoplasm, while capsids within
the nucleus are relatively devoid of tegument. These ﬁndings suggest
there are a limitednumberof candidate proteins capable of participating
in the pUL46–capsid complex.
The model presented in Fig. 7 provides a possible mechanistic
explanation of how membrane and capsid association with pUL46
contribute to its incorporation and topology within the virion. Fol-
lowing pUL46 synthesis, the protein is targeted to cellularmembranes,
thereby facilitating its localization to a TGN-derived vesicle. During
secondary envelopment, the capsid comes within close proximity to
the tegument proteins (including pUL46) localized on the TGN-derived
vesicle. Whether pUL46 is tethered to these vesicles by binding to a
glycoprotein or another tegument protein is not known at this time.
The juxtapositioning of the capsid to the membrane allows the
membrane-associated pUL46 to interact with the capsid or with a
capsid-associated protein. During secondary envelopment pUL46
becomes strongly associated with the surface of the capsid. While
the results reported in our studies with pUL46 do not provide direct
evidence for this model, previous ﬁndings from other laboratories
suggest the assembly of a tegument may indeed be a dynamic process.
Electron tomography studies of HSV-1 capsids undergoing primary
envelopment show the presence of bridging structures between the
capsid and the inner nuclearmembrane (Baines et al., 2007).While the
identity of the proteins comprising these structures is unknown, both
tegument proteins and viral glycoproteins are found in primary
enveloped viral particles (Granzow et al., 2001; Naldinho-Souto
et al., 2006). These bridging structures could be part of an intermediate
envelopment step that allows the capsid to be tethered to the inner
nuclear membrane. A secondary line of evidence for the dynamictegumentation model is that proteins found in primary enveloped
particles are not found in the mature virion (Fuchs et al., 2002). These
proteins are likely removed from these particles upon de-envelopment
at the outer nuclear membrane. However, the mechanism responsible
for dissociation of these proteins from the capsid is unclear. Further
evidence for dynamic interactions of tegument proteins can be
inferred from examining the tegument composition of herpesvirus L
particles that lack capsids (Szilagyi and Cunningham, 1991). In order
for tegument proteins to be packaged into L particles, the tegument
proteins must trafﬁc through the cell to the site of assembly
(a tegument/glycoprotein containing vesicle) by a capsid-independent
mechanism. However, select tegument proteins i.e. pUL36 are present
in L particles, but analysis of infectious virions reveals that pUL36 is
selectively associated with the capsid when the viral envelope is
removed with detergent or when the capsid enters the cytoplasm
during infection of the cell (Dargan et al., 1995; Granzow et al., 2005;
Szilagyi and Cunningham, 1991; Wolfstein et al., 2006). These
paradoxical results could be explained by the transient association of
pUL36with the future viral envelope until ﬁnal envelopment, at which
time pUL36 becomes irreversibly bound to the capsid.
The mechanisms responsible for ensuring that all tegument
proteins are incorporated into herpesvirus virions is one of the more
complex areas of herpesvirus assembly. The entire process appears
more complicated than the simple two layer convention of the “outer
and inner” tegument model. Future studies comparing the tegument
structure of viral particles inside the infected cell versus those found
in extracellular virions may provide insightful information as to how
the tegument achieves its ﬁnal architecture within the mature virion.
Materials and methods
Cells and viruses
Vero cells (ATCCCCL-81) andA7 (humanmelanoma)were grown in
Dulbecco's modiﬁed Eagles medium (DMEM) (GIBCO) supplemented
with 5% fetal bovine serum (FBS), 2.25% sodium bicarbonate, 25 mM
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streptomycin (131 ug/ml). Infected cells were grown in 2% FBS
supplemented DMEM. The viruses used in this study were strains
KOS (Smith, 1964), GHSV-UL46 (kindly provided by Dr. Mark Willard),
an HSV-1 expressing pUL46 and green ﬂuorescent protein (GFP) fusion
protein (Willard, 2002) and K23Z (kindly provided by Dr. Preshant
Desai), an HSV-1 mutant defective in capsid triplex protein VP23
synthesis (Desai et al., 1993; Person and Desai, 1998).
Antisera
pUL46-GST fusion protein was puriﬁed from E. coli and inoculated
into rabbits for antibody production by Cocalico Biologicals. Anti-HA,
anti-actin, anti-VP16, and anti-GST were purchased from Sigma, Santa
Cruise Biologicals, Clontech, and Rockland respectively. Rabbit poly-
clonal antibodies to VP5 (McNabb, unpublished data), VP22 (Loomis
et al., 2003), and pUL11 (Loomis et al., 2003) have been described
previously. A rabbit polyclonal antibody to pUL37 was generously
provided by Dr. Frank Jenkins (Schmitz et al., 1995).
Plasmids
Construction of a pUL46-hemagglutinin (HA) fusion protein expres-
sion vectorwas initiatedby PCRampliﬁcation of theUL46gene fromKOS
HSV-1 genomic DNA using Platinum Taq polymerase (Invitrogen). The
forward primer (containing a BglII site) used in the ampliﬁcation was
complementary to the sequence located 45 bp upstream of the UL46
start codon. The reverse primer (containing an EcoRI site) was
complementary to the 3′ end of the UL46 gene but with a mutation to
the stop codon of UL46 (TGA to TGC) to allow for read-through. The
ampliﬁcation product was cut with BglII and EcoRI and cloned into the
multiple cloning site (MCS) of an HA encoding plasmid (Loomis et al.,
2006). Plasmids encoding pUL46-HA amino-terminal deletion proteins
were constructed by PCR ampliﬁcation of the full-lengthUL46-HAas the
template, using forward primers (containing an XhoI site and ATG start
codon) complementary to sequences within the UL46 gene. The reverse
primer was the same EcoRI containing primer used for full-length UL46
construction. The PCR products were cut with XhoI and EcoRI and
inserted into amodiﬁed version of the pUL46-HAexpression vector. The
plasmid was modiﬁed by insertion of an XhoI site, by QuickChange XL
Site-Directed Mutagenesis (Stratagene) immediately upstream of the
UL46 start codon. This modiﬁcation allowed the cloning of amino-
terminal deletion constructs into the vectorwhilemaintaining the45bp
upstream of the start codon. Carboxy-terminal pUL46-HA deletion
plasmids were constructed using reverse primers (containing EcoRI
sites) complementary to sequences within the UL46 gene. The forward
primer used for carboxy-terminal deletions was the same BglII contain-
ing primer utilized in the construction of the full-length pUL46-HA
plasmid. The PCR products were cut with BglII and EcoRI and inserted
into the HA expression vector. The VP16 encoding plasmid was
constructed by PCR ampliﬁcation using a forward primer (containing a
HindIII site) complementary to sequences 120 bp upstream of the
VP16 start codon. The reverse primer (containing a BamHI site) was
complementary to the 3′ end of the UL48 gene. The ampliﬁcation
product was cut withHindIII and BamHI and cloned into the MCS of the
pEGFP-N2 vector (Clontech). The retention of the stop codonwithin the
UL48 sequence results in expression of VP16 without the carboxy-
terminal GFP fusion protein. Plasmids encoding VP22 fused to GFP
(Brignati et al., 2003) and pUL11 fused to GST (Loomis et al., 2003) were
described previously. The plasmid encoding pUL46 fused to GST was
kindly provided by Dr. Russell Diefenbach (Vittone et al., 2005).
Confocal microscopy
Vero cells were infected with GHSV-UL46 at a multiplicity of
infection (MOI) of 10. At 9 h post-infection the cells were ﬁxed in 4%paraformaldehyde (PFA) in PBS followed by cell permeabilization in
acetoneat−20 °C for2min. The cellswere incubated in 10%FBS-PBS for a
minimum of 1 h prior to incubation in primary antibody diluted in 10%
FBS-PBS. After incubation in primary antibody for 1 h, the cells were
washed 3 times in 10% FBS-PBS and subsequently incubated in
secondary antibody conjugated to Alexa Fluor 555 (Molecular Probes)
diluted in 10% FBS-PBS for 30 min. After incubation in secondary
antibody, the cells werewashed 3 times in 10% FBS-PBS andmounted in
DAPI containing Antifade reagent (Molecular Probes). To determine the
cellular localization of pUL46 relative to VP22 in the absence of other
HSV-1 proteins, A7 cells were cotransfected using Lipofectamine 2000
(Invitrogen)withplasmids encodingVP22 fused toGFPandpUL46 fused
to the HA epitope tag. At 24 h post-transfection the cells were ﬁxed and
prepared for immunoﬂuorescence as described above. Intrinsic GFP
ﬂuorescence and immunoﬂuorescence were detected by using a Leica
TSC SP2 AOBS confocal microscope. Images were formatted in Adobe
Photoshop, version 7.0.
Membrane ﬂotation
The membrane ﬂotation protocol was adapted from Brignati et al.,
2003. Vero cells were transfected with plasmids encoding UL46-HA or
VP16 constructs. At 24 h post-transfection the cells were scraped into
PBS, washed and resuspended in hypotonic lysis buffer (50mMTris–HCl
[pH7.4] and3mMMgCl2) supplementedwithProtease Inhibitor Cocktail
(Sigma). Following incubationon ice for 15min, the cellswere lysedby10
passages through a 25 gauge needle. Post-nuclear supernatants (PNS)
were obtainedbycentrifugation at 500×g for 10min. PNS treatmentwith
extraction reagents (1 M NaCl, 0.1 M Na2CO3 [pH 11], 4 M urea, or 1%
Triton X-100) was performed for 30 min at 4 °C (Fujiki et al., 1982;
Jasenosky et al., 2001; Merdes et al., 1991; Brunkener and Georgatos,
1992; Pahud et al., 1998). Resulting supernatants were added to sucrose
(prepared in NTE (100 mM NaCl, 10 mM Tris–HCl [pH 7.4] and 1 mM
EDTA)) to obtain a 72% sucrose concentration. A discontinuous gradient
was formedbyoverlaying thismixturewith 65% sucrose followed by 10%
sucrose. The resulting gradient was centrifuged at 150,000 ×g for 18 h.
Gradients were fractionated and trichloroacetic acid (TCA) was added to
the resulting fractions to a 10% ﬁnal concentration and subsequently
incubated at 4 °C overnight. Following centrifugation, the resulting
pellets were washed in 100% ethanol and dried prior to solubilization in
SDS-PAGE sample buffer (50mMTris–HCl [pH 6.8],10% glycerol, 2% SDS,
5% β-mercaptoethanol [β-ME]). Western blotting was performed using
secondary antibodies conjugated to horseradish peroxidase, ECL
reagents (Pierce), and Kodak BioMax XAR ﬁlm. The resulting blots
were quantitated by densitometry. The relative amount of signal in each
fractionwas calculated by adding the intensity of all fractionswithin the
gradient and dividing each fraction's intensity by this total.
Virion incorporation assay
Conﬂuent monolayers of Vero cells grown in 100-mm plates were
transfectedwith the pUL46-HA encoding plasmid using Lipofectamine
2000 (Invitrogen), according to the manufacturer's instructions. At
20 h post-transfection, cells were infected with HSV-1 KOS strain at a
MOI of 10. At 20 h post-infection (40 h post-transfection), the medium
was removed and centrifuged at 1000 ×g for 10 min at 4 °C to remove
cellular debris. The supernatant was retained and extracellular virions
were pelleted by centrifugation (26,000 RPM for 1 h in a Beckman
SW41 rotor) through a 30% (wt/vol) sucrose cushion (1.7 ml) in NTE.
Pelleted virions and the infected cells were disrupted in SDS-PAGE
sample buffer prior to Western blotting.
Phosphatase treatment of pUL46
Vero cells were transfected with the pUL46-HA expressing
plasmid. 20 h post-transfection, the cells were infected with KOS at
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were solubilized in lysis buffer (50 mM Tris–HCl [pH 7.4], 150 mM
NaCl, 1% NP-40 (IGEPAL CA-630; Sigma), 0.5% deoxycholate) plus
Protease Inhibitor Cocktail (Sigma). pUL46-HA proteins were immu-
noprecipitated with anti-HA antibody and protein A agarose beads
(Roche). After multiple washes in lysis buffer the beads were
resuspended in either 1X phosphatase reaction buffer only or 1X
phosphatase reaction buffer plus 50 U of Calf Intestinal Alkaline
Phosphatase (CIAP) (Promega). The phosphatase reaction was incu-
bated at 37 °C for 30 min, followed by multiple washes of the agarose
beads in 1× phosphatase reaction buffer. The immunoprecipitated
proteins were solubilized in SDS-PAGE sample buffer for subsequent
Western blotting with the anti-HA antibody.
Analysis of detergent treated virions
Vero cells were infected with HSV-1 KOS at an MOI of 0.1. At 40 h
post-infection media was collected and centrifuged at 1000 ×g for
10 min to remove cellular debris. Virions were pelleted through 30%
(wt/vol) sucrose by centrifugation of the cleared media at 27,000 RPM
in a Beckman SW32 rotor for 60 min. Pelleted virions were
resuspended in 1 M NaCl phosphate buffered saline (PBS). Following
resuspension, virions were either mock treated or incubated with 1%
NP40 at 4 ° C for 30 min. Samples were then layered on top of a 20–
50% (wt/wt) linear sucrose gradient and centrifuged at 24,500 RPM for
1 h at 4 °C in a Beckman SW41 rotor. Gradients were fractionated and
TCA precipitated as described above. Samples were analyzed by SDS-
PAGE followed by Western blotting. The resulting blots were
quantitated by densitometry. The relative amount of signal in each
fraction was calculated by adding the intensity of all fractions within
the gradient and dividing each fraction's intensity by this total.
Puriﬁcation of GST fusion proteins
The vectors encoding GST and pUL11-GST were transformed into
BL21 competent cells (Stratagene). Due to the increased breakdown of
the pUL46-GST fusion protein, the pUL46-GST vector was transformed
into BL21-CodonPlus competent cells (Stratagene). Following over-
night incubation of the transformed cells, the cultures were diluted
1:10 in yeast extract tryptone media (2XYT). GST and pUL11-GST
cultures were grown at 37 °C to A600=0.4. To induce expression
1.0 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) was added to
the cultures followed by further incubation at 37 °C for 3 h. The
pUL46-GST cultures were grown at room temperature to A600=0.4. To
induce expression 0.1 mM IPTG was added to the cultures followed by
further incubation at room temperature for 6 h. The bacterial cultures
were centrifuged at 100,000 ×g for 10 min at 4 °C. The bacterial pellets
were subjected to one freeze/thaw cycle and resuspended in PBS
containing Complete Mini protease inhibitors (Roche). Following
sonication of the suspension, Triton X-100 was added to a 1%
concentration. The suspension was incubated on ice for 30 min and
clariﬁed by centrifugation at 27,000 ×g for 15 min at 4 °C. Clariﬁed
lysates were incubated at 4 °C with glutathione-Sepharose 4B beads
(Pharmacia) for 3 h. The beads were washed in 1% Triton X-100
containing PBS and the yield of each puriﬁed GST fusion protein was
determined by SDS-PAGE and subsequent staining with Coomassie
blue to detect recombinant proteins.
UL46-GST pull-down of HSV-1 capsids
Vero cells were infected with KOS at a MOI of 10 for 18 h. The
nuclear capsid isolation protocol used by our lab was previously
described (Bucks et al., 2007). Following infection, cells were
harvested and washed in PBS. Cells were lysed in nuclei isolation
buffer (NIB) (1% NP40, 150 mM NaCl, 50 mM Tris–HCl [pH 7.4], 3 mM
MgCl2) and supplemented with Protease Inhibitor Cocktail. Lysed cellswere incubated for 30 min on ice. Nuclei were pelleted by
centrifugation at 500 ×g for 5 min at 4 °C. Nuclei were washed 3
times and resuspended in NIB. The nuclei were lysed by 3 cycles of
freezing and thawing followed by cup sonication on ice for 3 min
within a cup-horn attachment. Following sonication, the supernatant
was treated with RQ1 DNase (Promega) for 15 min at 37 °C. The
nuclear lysate was then cleared of debris by centrifugation at
8000 RPM for 30 min in a Beckman SW41 rotor. After centrifugation,
the capsids within the nuclear extract were pelleted through a 35%
(wt/wt) sucrose cushion by centrifugation at 24,500 RPM for 60min in
a Beckman SW41 rotor. The resulting capsid pellet was resuspended in
capsid binding buffer (CBB) (0.5% NP40,150mMNaCl, 50mMTris–HCl
[pH 7.4]) supplemented with Protease Inhibitor Cocktail. Capsids were
mixed with GST fusion proteins immobilized on glutathione beads at
37 °C for 30 min. The beads were then washed 5 times with CBB at
room temperature. The washed beads were mixed with SDS-PAGE
sample buffer and analyzed byWestern blotting. In order to determine
the presence of HSV-1 C capsids, an aliquot of washed beads was used
to isolate viral genomic DNA via the Qiagen DNAeasy Kit (Qiagen). The
puriﬁed genomic DNA was used in conjunction with UL47 compli-
mentary primers (CGGCCTCCATCCGCGCTGTGGGGTC and GCATGG-
GCGTGGCGGGCCTCCCAGCCCG) for PCR ampliﬁcation. The ampliﬁed
UL47 DNA was visualized in an ethidium bromide stained agarose gel.
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